1
Study of BTK Inhibitor LOXO-305 Versus Approved BTK Inhibitor Drugs in Patients With Mantle Cell Lymphoma (MCL)
Condition(s):Lymphoma, Mantle-CellLast Updated:March 23, 2021Recruiting
Lymphoma, Mantle-Cell: 1088 Clinical Trials, Page 1 of 109
Hide Studies Not Open or Pending
2
CD19-targeted CAR T Cells for Relapsed and Refractory (R/R) Mantle Cell Lymphoma
Condition(s):Mantle Cell LymphomaLast Updated:March 18, 2021Recruiting
3
Ixazomib and Rituximab in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma
Condition(s):Recurrent Mantle Cell Lymphoma; Refractory Mantle Cell LymphomaLast Updated:February 5, 2020Recruiting
4
Combined CT Colonography and PET Imaging in Mantle Cell Lymphoma
Condition(s):Mantle Cell Lymphoma; LymphomaLast Updated:December 6, 2012Withdrawn
5
Safety and Efficacy of RAD001 in Patients With Mantle Cell Lymphoma Who Are Refractory or Intolerant to Velcade® Therapy.
Condition(s):Lymphoma, Mantle- CellLast Updated:October 22, 2020Completed
6
Bendamustine Plus Rituximab for Mantle Cell Lymphoma: a Multicenter Retrospective Analysis(BR-MCL)
Condition(s):Mantle Cell LymphomaLast Updated:March 18, 2020Recruiting
7
A Study of Ibrutinib in the Treatment of Chronic Lymphocytic Leukemia and Mantle-cell Lymphoma in Routine Clinical Practice
Condition(s):Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Mantle-CellLast Updated:February 10, 2021Recruiting
8
Chemotherapy Followed by Zevalin for Relapsed Mantle Cell Lymphoma
Condition(s):Mantle Cell LymphomaLast Updated:April 24, 2014Completed
9
A Disease Registry of Patients With Mantle Cell Lymphoma
Condition(s):Mantle Cell LymphomaLast Updated:March 22, 2021Recruiting
10
Study of the Bruton’s Tyrosine Kinase (BTK) Inhibitor Ibrutinib in Participants With Relapsed or Refractory Mantle Cell Lymphoma
Condition(s):Lymphoma, Mantle-cellLast Updated:January 24, 2017Completed